Comparing Screening Methods for Detection of Early-Stage Gastric Cancer in People with a CHD1 Genetic Mutation
https://www.facingourrisk.org/research-clinical-trials/study/293/comparing-screening-methods-for-detection-of-early-stage-gastric-cancer-in-people-with-a-chd1-genetic-mutation
Clinicaltrials.gov identifier:
NCT04535414 (https://clinicaltrials.gov/show/NCT04535414)
Gastric cancer screening study for people with a CHD1 inherited mutation
About the Study
This study is no longer recruiting patients.
This study will compare a new technique of screening for a type of inherited gastric cancer known as diffuse hereditary gastric cancer (DHGC) to see if it can identify cancer better than the current recommended screening. Participants will be assigned by chance to one of two groups to receive screening by the current screening technique, called the Cambridge method, or the new screening technique, called the Bethesda protocol.
This Study is Open To:
This study is no longer recruiting patients.
This Study is Not Open To:
This study is no longer recruiting patients.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.